Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia

Franco Locatelli*, Alexis A Thompson, Janet L. Kwiatkowski, John B. Porter, Adrian J. Thrasher, Suradej Hongeng, Martin G. Sauer, Isabelle Thuret, Ashutosh Lal, Mattia Algeri, Jennifer Schneiderman, Timothy S. Olson, Ben Carpenter, Persis J. Amrolia, Usanarat Anurathapan, Axel Schambach, Christian Chabannon, Manfred Schmidt, Ivan Labik, Heidi ElliotRuiting Guo, Mohammed Asmal, Richard A. Colvin, Mark C. Walters

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science